PE20000324A1 - Preconcentrado en emulsion - Google Patents

Preconcentrado en emulsion

Info

Publication number
PE20000324A1
PE20000324A1 PE1999000178A PE00017899A PE20000324A1 PE 20000324 A1 PE20000324 A1 PE 20000324A1 PE 1999000178 A PE1999000178 A PE 1999000178A PE 00017899 A PE00017899 A PE 00017899A PE 20000324 A1 PE20000324 A1 PE 20000324A1
Authority
PE
Peru
Prior art keywords
fatty acid
composition
component
mono
diglycerides
Prior art date
Application number
PE1999000178A
Other languages
English (en)
Inventor
Michael Ambuhl
Barbara Luckel
Friedrich Richter
Armin Meinzer
Barbara Haberlin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20000324(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9804742.6A external-priority patent/GB9804742D0/en
Priority claimed from GBGB9805104.8A external-priority patent/GB9805104D0/en
Priority claimed from GBGB9805199.8A external-priority patent/GB9805199D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20000324A1 publication Critical patent/PE20000324A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Abstract

SE REFIERE A UNA COMPOSICION EN LA FORMA DE UN PRECONCENTRADO EN EMULSION O EN MICROEMULSION QUE COMPRENDE: a)DE 1%-15% DE UN COMPONENTE HIDROFILICO TAL COMO UNA CICLOSPORINA O UN MACROLIDO COMO FK 506; b)DE 5%-50% DE UN COMPONENTE LIPOFILICO TAL COMO CITRATO DE TRIETILO O CITRATO DE ACETILTRIETILO, ESTER DE ACIDO GRASO DE C6-C10 DE POLIETILENGLICOL, DIESTER DE ACIDO GRASO C6-C16 DE GLICEROL, MONOESTER DE ACIDO GRASO C6-C14 DE GLICERIDO, UNA MEZCLA DE MONOGLICERIDOS O DIGLICERIDOS DE ACIDOS GRASOS C6-C16, MONOESTER DE ACIDO GRASO DE C6-C12 DE PROPILENGLICOL, ACIDOS GRASOS Y ALCOHOLES, ENTRE OTROS; c)5%-85% DE UN COMPONENTE LIPOFILICO, TAL COMO TRIGLICERIDO DE ACIDO GRASO, MONO, DI, TRIGLICERIDOS MIXTOS, ACEITES VEGETALES ETOXILADOS TRANSESTERIFICADOS; d)5%-85% DE UN TENSIOACTIVO TAL COMO PRODUCTOS DE REACCION DE ACEITE VEGETAL NATURAL O HIDROGENADO Y OXIDO DE ETILENO, ESTERES DE ACIDO GRASO DE SORBITAN DE POLIOXIETILENO; SI EL SEGUNDO COMPONENTE ES CITRATO DE TRIETILO, LA COMPOSICION NO COMPRENDE ETANOL; O SI ES UNA MEZCLA DE MONO Y DIGLICERIDOS DE ACIDOS GRASOS DE C8-C10, LA COMPOSICION NO COMPRENDE TRIGLICERIDO DE ACIDO GRASO C6-C12; Y SE CARACTERIZA POR EL TAMANO DE PARTICULAS DE 200 nm. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNES O INFLAMATORIAS, RECHAZO DE TRASPLANTES, RESISTENCIA DE FARMACOS
PE1999000178A 1998-03-06 1999-03-04 Preconcentrado en emulsion PE20000324A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9804742.6A GB9804742D0 (en) 1998-03-06 1998-03-06 Organic compounds
GBGB9805104.8A GB9805104D0 (en) 1998-03-10 1998-03-10 Organic compounds
GBGB9805199.8A GB9805199D0 (en) 1998-03-11 1998-03-11 Organic compounds

Publications (1)

Publication Number Publication Date
PE20000324A1 true PE20000324A1 (es) 2000-04-13

Family

ID=27269231

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000178A PE20000324A1 (es) 1998-03-06 1999-03-04 Preconcentrado en emulsion

Country Status (30)

Country Link
EP (2) EP1059913B1 (es)
JP (2) JP2002505271A (es)
KR (1) KR100443306B1 (es)
CN (1) CN1195495C (es)
AR (1) AR015729A1 (es)
AT (1) ATE277599T1 (es)
AU (1) AU749217B2 (es)
BE (3) BE1012400A5 (es)
BR (1) BR9908597A (es)
CA (1) CA2322845C (es)
CO (1) CO4930289A1 (es)
CZ (1) CZ301967B6 (es)
DE (2) DE69920668T2 (es)
ES (1) ES2228014T3 (es)
FR (4) FR2775596B1 (es)
GB (1) GB2350791B (es)
HK (2) HK1034038A1 (es)
HU (1) HUP0101080A3 (es)
ID (1) ID25908A (es)
IL (2) IL138248A0 (es)
IT (1) IT1313550B1 (es)
MY (1) MY129274A (es)
NO (1) NO331800B1 (es)
NZ (1) NZ506644A (es)
PE (1) PE20000324A1 (es)
PT (1) PT1059913E (es)
SK (1) SK285139B6 (es)
TR (1) TR200002586T2 (es)
TW (3) TWI257870B (es)
WO (1) WO1999044584A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2257917C2 (ru) * 1998-12-11 2005-08-10 Фармасолюшнз, Инк. Самоэмульгирующиеся композиции для плохорастворимых в воде лекарственных препаратов
IL143604A0 (en) * 1998-12-30 2002-04-21 Dexcel Ltd Dispersable concentrate for the delivery of cyclosporin
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
GB2362573A (en) * 2000-05-25 2001-11-28 Cipla Ltd Cyclosporin formulation
AU1043201A (en) * 1999-11-02 2001-05-14 Cipla Limited Cyclosporin formulation
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2003002095A1 (fr) * 2001-06-28 2003-01-09 Chugai Seiyaku Kabushiki Kaisha Preparation d'une micro-emulsion de type huile-eau
US6960563B2 (en) 2001-08-31 2005-11-01 Morton Grove Pharmaceuticals, Inc. Spontaneous emulsions containing cyclosporine
GB2391471B (en) * 2002-08-02 2005-05-04 Satishchandra Punambhai Patel Pharmaceutical compositions
KR20040047056A (ko) * 2002-11-29 2004-06-05 한미약품 주식회사 비페닐디메틸디카복실레이트의 경구용 마이크로에멀젼조성물
US8802116B2 (en) 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
KR20040084240A (ko) * 2003-03-27 2004-10-06 (주) 코스메디 고형지질나노입자, 이를 함유하는 활성성분 전달용약학조성물 및 이의 제조방법
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
EP1807049A1 (en) * 2004-10-29 2007-07-18 Novartis AG Spontaneously dispersible pharmaceutical compositions
ES2573539T3 (es) * 2005-03-21 2016-06-08 Teva Czech Industries S.R.O. Inhibidor de la cristalización y su uso en cápsulas de gelatina
CN101032620B (zh) * 2007-03-08 2010-05-19 上海凯昭医药科技有限公司 一种环孢素自乳化制剂及其制备方法
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
DK2548456T3 (en) 2008-03-20 2015-09-28 Virun Inc Emulsions including (comprising) a PEG derivative of tocopherol
BRPI0909185A2 (pt) 2008-03-20 2015-08-25 Virun Inc Derivado de vitamina e e seus usos
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP5567909B2 (ja) * 2010-06-17 2014-08-06 東洋カプセル株式会社 タクロリムス含有カプセル剤
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
KR101458466B1 (ko) * 2013-06-24 2014-11-07 한국화학연구원 면역억제제가 봉입된 마이셀을 함유하는 경구제
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
BR112018005315A2 (pt) 2015-09-17 2018-10-09 Jrx Biotechnology Inc abordagens para aprimorar hidratação ou umidificação de pele
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
JP2022513635A (ja) * 2018-11-26 2022-02-09 ヘピオン ファーマシューティカルズ インコーポレイテッド シクロスポリン類似体の医薬製剤
WO2024014958A2 (en) * 2022-07-15 2024-01-18 Seranovo Holding B.V. Lides formulation platform
WO2024014959A2 (en) * 2022-07-15 2024-01-18 Seranovo Holding B.V. Micelle-generating formulations with improved hydrophobicity
CN117797093A (zh) * 2024-02-29 2024-04-02 中国农业科学院农业环境与可持续发展研究所 一种以大环内酯类药物为活性成分的兽用口服纳米液体制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
PT589843E (pt) * 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
EP0694308A4 (en) * 1994-02-17 1997-09-10 Shiseido Co Ltd CYCLOSPORIN EMULSION COMPOSITION
JP3131112B2 (ja) * 1994-02-17 2001-01-31 株式会社資生堂 シクロスポリン含有乳化組成物
MX9702699A (es) * 1994-10-26 1997-06-28 Novartis Ag Composiciones farmaceuticas.
IL129547A (en) * 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
CA2313024C (en) * 1997-12-10 2008-06-03 Severson, Mary L. Pharmaceutical compositions containing an omega-3 fatty acid oil

Also Published As

Publication number Publication date
EP1354582A3 (en) 2004-06-09
FR2800277B1 (fr) 2004-06-25
FR2853546A1 (fr) 2004-10-15
TW200422057A (en) 2004-11-01
TWI236912B (en) 2005-08-01
NO331800B1 (no) 2012-04-02
EP1059913A1 (en) 2000-12-20
SK13192000A3 (sk) 2001-02-12
FR2881956A1 (fr) 2006-08-18
ID25908A (id) 2000-11-09
TWI257870B (en) 2006-07-11
EP1354582A2 (en) 2003-10-22
MY129274A (en) 2007-03-30
HK1033277A1 (en) 2001-08-24
ES2228014T3 (es) 2005-04-01
CN1292684A (zh) 2001-04-25
TWI248368B (en) 2006-02-01
CZ301967B6 (cs) 2010-08-18
SK285139B6 (sk) 2006-07-07
CZ20003222A3 (cs) 2000-12-13
BR9908597A (pt) 2000-11-14
ATE277599T1 (de) 2004-10-15
DE19983012T1 (de) 2001-02-01
NO20004299L (no) 2000-08-29
KR20010041657A (ko) 2001-05-25
FR2775596B1 (fr) 2004-12-24
DE69920668T2 (de) 2005-10-06
AR015729A1 (es) 2001-05-16
IL138248A0 (en) 2001-10-31
GB2350791A (en) 2000-12-13
HK1034038A1 (en) 2001-10-12
AU2836199A (en) 1999-09-20
CO4930289A1 (es) 2000-06-27
NO20004299D0 (no) 2000-08-29
BE1013423A5 (fr) 2002-01-15
TR200002586T2 (tr) 2000-11-21
EP1059913B1 (en) 2004-09-29
CA2322845A1 (en) 1999-09-10
GB0021495D0 (en) 2000-10-18
JP2004189753A (ja) 2004-07-08
KR100443306B1 (ko) 2004-08-09
FR2800277A1 (fr) 2001-05-04
HUP0101080A3 (en) 2001-12-28
CA2322845C (en) 2009-12-08
ITMI990452A1 (it) 2000-09-05
GB2350791B (en) 2003-04-02
DE69920668D1 (de) 2004-11-04
IL138248A (en) 2006-06-11
IT1313550B1 (it) 2002-09-09
BE1013648A5 (fr) 2002-05-07
BE1012400A5 (fr) 2000-10-03
PT1059913E (pt) 2005-01-31
FR2775596A1 (fr) 1999-09-10
FR2853546B1 (fr) 2006-04-07
JP2002505271A (ja) 2002-02-19
CN1195495C (zh) 2005-04-06
WO1999044584A1 (en) 1999-09-10
HUP0101080A2 (hu) 2001-08-28
AU749217B2 (en) 2002-06-20
NZ506644A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
PE20000324A1 (es) Preconcentrado en emulsion
EP0953630B1 (en) Transesterification products of corn oil and glycerol and their use in pharmaceutical compositions
EP2636313B1 (en) Glyceride composition obtainable from shea oil
CA2469647A1 (en) Extraction and winterization of lipids from oilseed and microbial sources
JP2002505271A5 (es)
RU2001129365A (ru) Фармацевтические композиции для перорального применения, содержащие длинноцепочечные триглицериды и липофильные поверхностно-активные вещества
EP0525915A1 (en) Edible oil/fat compositions
RU2014138996A (ru) Гормонсодержащая эмульсия
CZ291214B6 (cs) Potravinářský prostředek s obsahem organického gelu
US20140275596A1 (en) Algal omega 7 and algal omega 3 blend compositions
DE60132508D1 (de) Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels
JP2013515018A5 (es)
ES2572133T3 (es) Composiciones farmacéuticas que comprenden un derivado de camptotecina
KR930000108A (ko) 화장제 올레오젤
CA2531317A1 (en) Antioxidant fat or oil composition containing long-chain highly unsaturated fatty acid
CN105072917B (zh) 脂肪组合物
Gunstone et al. Glyceride studies. Part IV. The component glycerides of ten seed oils containing linoleic acid
WO2015162277A1 (en) Emulsified krill phospholipid compositions
TW200529763A (en) Fat composition
EP2330917B1 (en) Fat or oil compositon
JP2905275B2 (ja) 酸化防止剤組成物
JP2000109882A (ja) 油性粉末、製造方法および用途
EP2749632B1 (en) Oil/fat composition
EP0441081B1 (fr) Système tensio-actif à base d'un sucroglycéride et son application à la fabrication d'aliments d'allaitement pour jeunes animaux
KR20000022734A (ko) Ｓｅｄｄｓ로 제제화한 발기부전치료용 주입액제

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed